# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jackie Robinson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML037-SYN-TD
- Date: 1971-07-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marcus Delacroix-Hale, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for visit for blurred vision and new floaters, chest tightness on stairs, calf pain on walking and numb feet, in a man with long-standing diabetes six weeks after the death of his son. **S**

## Objective

Hemoglobin A1c: 10.4% (high); Glucose (random): 248 mg/dL (high); Sodium: 137 mmol/L; Potassium: 4.6 mmol/L; Creatinine: 1.12 mg/dL; eGFR (CKD-EPI 1966, race-free): 79 mL/min/1.73 m² (low); Urine albumin-to-creatinine ratio: 86 mg/g (high); Total cholesterol: 226 mg/dL (high); LDL cholesterol: 142 mg/dL (high); HDL cholesterol: 38 mg/dL (low); Triglycerides: 230 mg/dL (high); ALT: 28 U/L; AST: 24 U/L; Hemoglobin: 13.9 g/dL; Platelets: 250 10*3/uL; Vitamin B12: 380 pg/mL; TSH: 1.8 mIU/L; PHQ-9: 9. All results are synthetic.

BP 152/92 mmHg; pulse 84 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 104 kg; BMI 32.1 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arranged; Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arranged; Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%); Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg); Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79; Chronic kidney disease G2 A2; Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulses; Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testing; History of two mild strokes a year ago, without lasting weakness; Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dL; Bereavement: his eldest son died in a car crash six weeks ago. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Continued without change: Metformin 1,000 mg oral tablet, one tablet twice daily with meals **S**
- Continued without change: Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70 **S**
- Continued without change: Lisinopril 20 mg oral tablet, one tablet daily **S**
- Started: Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake) **S**
- Continued without change: Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Started: Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutes **S**

## Plan

- Urgent retina consultation within 48 hours for blurred vision with new floaters in a man with long-standing diabetes: dilated examination, OCT, and treatment of any proliferative retinopathy or macular edema; same-day attendance for a curtain over the vision or flashes. Guideline: 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 (2026); Diabetic Retinopathy Preferred Practice Pattern (2025) **S**
- Glucose: continue metformin and basal insulin, titrated slowly by a written plan so that the A1c falls gradually; rescue glucagon; diabetes self-management education adapted for low vision (a talking glucose meter, an insulin pen with audible dose clicks, large-print plans). Guideline: 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs (2026) **S**
- Cardiovascular risk: atorvastatin increased to 80 mg, aspirin continued, baseline ECG; cardiology evaluation of exertional chest tightness with a pharmacologic stress test, since calf pain limits walking. Guideline: 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs (2026) **S**
- Legs and feet: comprehensive foot examination today; ankle-brachial index; daily foot checks with a magnifying mirror and a bright lamp, protective shoes; podiatry. Guideline: 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 (2026); 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease (2024) **S**
- Kidneys: repeat urine albumin and kidney function after any change in kidney medicines; no NSAIDs. Guideline: 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024) **S**
- Grief and mood: acknowledge the loss, PHQ-9 now and at three months, and an offer of the health center's grief counselor, which he accepted; call or text 988 if thoughts of self-harm ever arise. Guideline: 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026 (2026); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**
